Latest Glenmark Pharmaceuticals S.A. Stories

2014-07-03 08:23:49

MUMBAI,India, July 3, 2014 /PRNewswire/ -- - GBR 830 is an antagonistic monoclonal antibody with first in class potential for the treatment of autoimmune diseases targeting OX40, a co-stimulatory receptor on T cells - The antibody has successfully completed the Phase I enabling preclinical development program and a Phase I clinical trial application has been filed with The Netherlands authorities -...

2011-03-31 07:27:00

- Glenmark's first novel molecule for an oncology indication - GBR 401 is a monoclonal antibody targeting CD19. The antibody is implicated in treatment of B cell malignancies and inflammatory disorders mediated by B lymphocytes - CD19 is expressed earlier and more broadly in B-cell development than CD20 and represents a promising treatment approach - GBR401 has been developed using an advanced technology platform that greatly enhances the efficacy of...

Word of the Day
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'